Skip to main content

Table 1 Baseline demographic variables of diabetic and nondiabetic patients in the MASS V trial

From: Myocardial injury in diabetic patients with multivessel coronary artery disease after revascularization interventions

  Diabetic patients
n = 90
Nondiabetic patients
n = 112
P
Male (%) 68.9 66.1 0.78
Age (year)a 62.5 (55.0, 67.75) 62.0 (56.0, 68.0) 0.96
Hypertension (%) 86.7 83.0 0.61
Prior MI (%) 31.1 33.0 0.89
Angina (%) 89.9 89.3 1.0
3-Vessel CAD (%) 72.2 62.5 0.28
LAD disease (%) 88.9 90.2 0.95
LM disease (%) 20.0 25.9 0.41
SYNTAX scorea 21.0 (16.0, 26.9) 19.0 (14.0, 25.0) 0.27
EFa 0.67 (0.61, 0.75) 0.67 (0.61, 0.72) 0.56
Cholesterola 165.0 (134.0, 189.0) 168.0 (147.5, 197.0) 0.18
LDL-Cholesta 93.0 (72.0, 117.0) 98.0 (78.0, 120.8) 0.17
HDL-Cholesta 37.0 (30.0, 42.0) 35.0 (29.3, 46.0) 0.74
Triglyceridesa 134.0 (91.0, 196.0) 128.0 (96.5, 167.5) 0.95
Glucosea 146.5 (116.2, 194.5) 100.0 (94.0, 112.0) < 0.001
A1ca 6.9 (6.05, 8.50)
Creatininea 1.00 (0.88, 1.22) 0.98 (0.85, 1.20) 0.65
  1. MI myocardial infarction, CAD coronary artery disease, LAD left anterior descending coronary artery, LM left main coronary artery, EF ejection fraction, LDL low-density lipoprotein, HDL high-density lipoprotein, A1c glycated hemoglobin
  2. aPresented as median (25th, 75th percentile)